RARA and Alzheimer disease: By continuing our search for multiligand agents from natural sources [16,17,18], we focused our attention in this work on compounds potentially able to bind and activate nuclear receptors such as RXRα, RARα, and PPARα/γ, because they may have therapeutical potential for the treatment of neurological diseases such as Alzheimer’s disease.